Learn English in the UK or in your own countryspacerUK courses and qualifications in the UK or in your own countryspacerThe best of British arts, media and designspacerPromoting British expertise in science, engineering, technology, environment and healthspacerGovernance and the rights of peoplespacerLibraries, information centres, seminars,  knowledge networks and the information society
What is the British Council?spacerVisit our worldwide network of officesspacerRead all about our collaborative workspacerFind our services, departments, libraries, personnel, etc.
The British Council home page

Health Insight May 2002: European drugs industry must keep pace with US

  Government ministers and top-level representatives of the UK pharmaceutical industry met in London last month to discuss how to respond to a recent EU report on improving the competitiveness of the European pharmaceutical industry. Co-chaired by UK Health Minister Lord Philip Hunt and Tom McKillop, CEO of AstraZeneca, this was the second meeting of the Ministerial Industry Strategy Group (MISG).

The EU report, produced by a Group of Ten (known as G10), bringing together government, industry and other parties from around Europe, was a response to the perception that over the last decade the European pharmaceutical industry has fallen behind the US. The report, presented to Commission President Romano Prodi earlier in the month, set out fourteen recommendations for action. The UK, as a leading location for the pharmaceutical industry in Europe, will be working with its partners in Europe to ensure that the recommendations are followed through. Lord Hunt said, ‘The UK has a thriving and successful pharmaceutical industry, and we want to keep it that way.’

Source: Press release (DoH)


Return to the main Health insight page | the main May 2002 Health insight page
  Produced in United Kingdom by The British Council © 2002. The British Council is the United Kingdom's international organisation for educational and cultural relations. Registered in England as a Charity.